Cell-free HPV DNA as a complementary biomarker to imaging in HPV-associated oropharyngeal squamous cell carcinoma: a narrative synthesis of key studies
Blood HPV DNA tests detect throat cancer recurrence months before imaging can, and combining them with scans offers a more sensitive surveillance approach than either method alone.
A narrative review synthesizes a decade of data showing that cell-free HPV DNA in OPSCC correlates with tumor burden, clears with effective therapy, and detects recurrence months before imaging. The review proposes a surveillance framework where ctHPV-DNA and imaging are complementary, with standardization of assays needed before clinical guideline adoption.
What the study was
- Study design
- Narrative review
- Population
- HPV-associated oropharyngeal SCC patients
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Expert Review of Molecular Diagnostics
Why it surfaced
Comprehensive narrative synthesis of ctHPV-DNA evidence; useful clinical framework for surveillance; review reduces score vs primary study.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.